RPRX

Royalty Pharma
D

RPRX

Arincen67/100B
67.290
USD
-0.26
(-0.38%)
Post Trading·68.800USD+1.510(+2.24%)
Last updated: · Delayed 15 min
Fair value63.11Plus+7%48Price 67.2994
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
OverviewFinancialsForecastEarningsDividendsCompany

Royalty Pharma price to sales (P/S) ratio

Royalty Pharma's P/S ratio is 11.45: its market cap of 29.96B USD over revenue of 2.62B USD in the last twelve months.

Today
11.45
Average, 5 years
7.06
Low, 5 years
4.77
High, 5 years
11.79

P/S ratio = market cap ÷ revenue (last 12 months) = 29.96B ÷ 2.62B = 11.45

Each day's market cap over the revenue of the last four quarters reported by that day.

P/S ratio by year and by quarter

Fiscal yearPeriod endingP/S ratioMarket capRevenue
Today11.4529.96B2.62B
FY202531 Dec 20257.0216.69B2.38B
FY202431 Dec 20245.0311.38B2.26B
FY202331 Dec 20235.3412.57B2.35B
FY202231 Dec 20227.7417.31B2.24B
FY202131 Dec 20217.2216.53B2.29B
FY202031 Dec 20209.1519.43B2.12B
FY201931 Dec 20198.6915.76B1.81B
FY201831 Dec 20188.7815.76B1.79B
FY201731 Dec 20179.8615.76B1.60B
FY201631 Dec 201614.3927.01B1.88B
FY201531 Dec 201516.3527.01B1.65B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Royalty Pharma's P/S ratio

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.